Atea Pharmaceuticals logo

Atea Pharmaceuticals Share Price Today

(NASDAQ: AVIR)

Atea Pharmaceuticals share price is $3.17 & ₹274.25 as on 20 Mar 2025, 2.30 'hrs' IST

$3.17

Market is closed - opens 7 PM, 20 Mar 2025

View live Atea Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Atea Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Atea Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Atea Pharmaceuticals share price movements

  • Today's Low: $3.14
    Today's High: $3.19

    Day's Volatility :1.6%

  • 52 Weeks Low: $2.75
    52 Weeks High: $4.15

    52 Weeks Volatility :33.66%

Atea Pharmaceuticals (AVIR) Returns

PeriodAtea Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
1.28%
-9999999.0%
0.0%
6 Months
-17.02%
-9999999.0%
0.0%
1 Year
-19.75%
-9999999.0%
0.0%
3 Years
-54.26%
-9999999.0%
-15.2%

Atea Pharmaceuticals (AVIR) Key Statistics

in dollars & INR

Previous Close
$3.17
Open
$3.17
Today's High
$3.1909
Today's Low
$3.14
Market Capitalization
$271.1M
Today's Volume
$162.7K
52 Week High
$4.145
52 Week Low
$2.75
Revenue TTM
$192.2M
EBITDA
$-131.8M
Earnings Per Share (EPS)
$-2.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
2.64%
Return On Equity TTM
-33.88%

How to invest in Atea Pharmaceuticals Stock (AVIR) from India?

It is very easy for Indian residents to invest directly in Atea Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atea Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atea Pharmaceuticals or AVIR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atea Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atea Pharmaceuticals shares which would translate to 0.273 fractional shares of Atea Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atea Pharmaceuticals, in just a few clicks!

Returns in Atea Pharmaceuticals (AVIR) for Indian investors in Rupees

The Atea Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atea Pharmaceuticals investment value today

Current value as on today

₹84,321

Returns

₹15,679

(-15.68%)

Returns from Atea Pharmaceuticals Stock

₹19,747 (-19.75%)

Dollar Returns

₹4,068 (+4.07%)

Indian investors sentiment towards Atea Pharmaceuticals (AVIR)

-33%

Period: Feb 17, 2025 to Mar 19, 2025. Change in 30 Days versus previous period

Search interest for Atea Pharmaceuticals Stock from India on INDmoney has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Atea Pharmaceuticals

  • BlackRock Inc

    10.73%

  • BML Capital Management LLC

    9.01%

  • FMR Inc

    7.61%

  • TANG CAPITAL MANAGEMENT LLC

    5.67%

  • Vanguard Group Inc

    5.53%

  • EcoR1 Capital, LLC

    3.96%

Analyst Recommendation on Atea Pharmaceuticals

Sell

    11%Buy

    33%Hold

    55%Sell

Based on 9 Wall street analysts offering stock ratings for Atea Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
1
Hold
3
3
3
Sell
5
5
5

Analyst Forecast on Atea Pharmaceuticals Stock (AVIR)

What analysts predicted

Upside of 122.92%

Target:

$7.07

Current:

$3.17

Insights on Atea Pharmaceuticals Stock (Ticker Symbol: AVIR)

  • Price Movement

    In the last 1 month, AVIR stock has moved up by 1.0%

  • AVIR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.3% return, outperforming this stock by 91.0%

  • AVIR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 53.4% return, outperforming this stock by 108.6%

  • Price to Sales

    ForAVIR every $1 of sales, investors are willing to pay $1.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Atea Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Atea Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Atea Pharmaceuticals (AVIR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atea Pharmaceuticals Inc logo
Atea Pharmaceuticals Inc
2.26%
-17.02%
-19.75%
-54.26%
-89.55%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
1.38%
-8.28%
71.25%
56.03%
155.84%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atea Pharmaceuticals Inc logo
Atea Pharmaceuticals Inc
11.84
NA
NA
-1.69
-0.34
-0.16
NA
5.2
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
0.52
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atea Pharmaceuticals Inc logo
Atea Pharmaceuticals Inc
Sell
$271.1M
-89.55%
11.84
0.0%
Alnylam Pharmaceuticals, Inc. logo
Alnylam Pharmaceuticals, Inc.
Buy
$31.6B
155.84%
NA
-12.37%

About Atea Pharmaceuticals

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antiviral therapeutics for patients with viral infections. Its lead product candidate is AT-527, an oral antiviral candidate that is in Phase 3 SUNRISE-3 clinical trial for the treatment of patients with COVID-19. The company also develops bemnifosbuvir in combination with ruzasvir, which is in Phase 2 clinical trial, for the treatment of hepatitis C virus (HCV); and a protease inhibitor for the treatment of COVID-19. It has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of Ruzasvir, an NS5A inhibitor, for the treatment of HCV. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Organization
Atea Pharmaceuticals
Employees
56
CEO
Dr. Jean-Pierre Sommadossi Ph.D.
Industry
Health Technology

Management People of Atea Pharmaceuticals

NameTitle
Dr. Jean-Pierre Sommadossi Ph.D.
Founder, Chairman, CEO & President
Ms. Andrea J. Corcoran J.D.
CFO, Executive VP of Legal & Secretary
Dr. Janet M. J. Hammond M.D., Ph.D.
Chief Development Officer
Dr. Maria Arantxa Horga M.D.
Chief Medical Officer
Ms. Jonae R. Barnes
Senior Vice President of Investor Relations & Corporate Communications
Mr. Adel Moussa Ph.D.
Executive Vice President of Chemistry
Mr. Xiao-Jian Zhou Ph.D.
Executive Vice President of Early Stage Development
Mr. John F. Vavricka
Chief Commercial Officer
Mr. Keith Pietropaolo
Executive VP of Clinical Sciences & Project Management
Dr. Jayanthi Wolf Ph.D.
Executive Vice President of Regulatory Affairs

Important FAQs about investing in AVIR Stock from India :

What is Atea Pharmaceuticals share price today?

Atea Pharmaceuticals share price today stands at $3.17, Open: $3.17 ; Previous Close: $3.17 ; High: $3.19 ; Low: $3.14 ; 52 Week High: $4.15 ; 52 Week Low: $2.75.

The stock opens at $3.17, after a previous close of $3.17. The stock reached a daily high of $3.19 and a low of $3.14, with a 52-week high of $4.15 and a 52-week low of $2.75.

Can Indians buy Atea Pharmaceuticals shares?

Yes, Indians can invest in the Atea Pharmaceuticals (AVIR) from India.

With INDmoney, you can buy Atea Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atea Pharmaceuticals at zero transaction cost.

How can I buy Atea Pharmaceuticals shares from India?

It is very easy to buy Atea Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atea Pharmaceuticals (AVIR) be purchased?

Yes, you can buy fractional shares of Atea Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Atea Pharmaceuticals stocks?

To start investing in Atea Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atea Pharmaceuticals Stock (AVIR)?

Today’s highest price of Atea Pharmaceuticals (AVIR) is $3.19.

Today’s lowest price of Atea Pharmaceuticals (AVIR) is $3.14.

What is today's market capitalisation of Atea Pharmaceuticals?

Today's market capitalisation of Atea Pharmaceuticals AVIR is 271.1M

What is the 52 Week High and Low Range of Atea Pharmaceuticals Stock (AVIR)?

  • 52 Week High

    $4.15

  • 52 Week Low

    $2.75

What are the historical returns of Atea Pharmaceuticals (AVIR)?

  • 1 Month Returns

    2.26%

  • 3 Months Returns

    -17.02%

  • 1 Year Returns

    -19.75%

  • 5 Years Returns

    -89.55%

Who is the Chief Executive Officer (CEO) of Atea Pharmaceuticals ?

Dr. Jean-Pierre Sommadossi Ph.D. is the current Chief Executive Officer (CEO) of Atea Pharmaceuticals.